Skip to main content

Advertisement

You are viewing the new article page. Let us know what you think. Return to old version

Research news | Open | Published:

Apoliprotein locus

In the October 5 Science, Len Pennacchio and colleagues, at the Lawrence Berkeley National Laboratory in California, describe how interspecies sequence comparison of the human and mouse apolipoprotein gene cluster (APOAI/CIII/AIV) led to the identification of a novel apolipoprotein-like gene (APOAV)(Science 2001, 294:169-173). Transgenic mice overexpressing the human APOAV gene have reduced plasma triglyceride levels, whereas APOAV-deficient knockout animals had four-times higher levels than controls. Pennacchio et al. found that single nucleotide polymorphisms (SNPs) in the human APOAV gene were linked to changes in plasma triglyceride levels. Thus, APOAV polymorphisms may serve as prognostic indicators for hypertriglyceridemia susceptibility and cardiovascular disease risk. The authors emphasize that comparative sequence analysis was key to the identification of APOAV.

References

  1. 1.

    Science, [http://www.sciencemag.org]

  2. 2.

    Lawrence Berkeley National Laboratory , [http://www.lbl.gov]

  3. 3.

    Comparative genomic analysis of cardiovascular gene regulation, [http://pga.lbl.gov/]

  4. 4.

    Human apolipoprotein A-I--C-III gene complex is located on chromosome 11

Download references

Rights and permissions

Reprints and Permissions

About this article

Keywords

  • Nucleotide
  • Cardiovascular Disease
  • Triglyceride
  • Single Nucleotide Polymorphism
  • Transgenic Mouse